DCT & HYBRID CLINICAL TRIALS

SAMD for Pharma

SAMD for Pharma

Enroll patients faster and keep them engaged longer for better clinical trial outcomes

Enroll patients faster and keep them engaged longer for better clinical trial outcomes

Award-winning human-centered design and 25 years of experience understanding complex patient and client needs across 1400 deployments has given us the knowledge to optimise and impact each touchpoint across clinical trial phases.

Award-winning human-centered design and 25 years of experience understanding complex patient and client needs across 1400 deployments has given us the knowledge to optimise and impact each touchpoint across clinical trial phases.

From screening to eConsent to onboarding and ongoing patient monitoring, our streamlined user journeys have helped clients around the world accelerate time to “first patient in” and engage and retain participants through the study and beyond with minimal dropout.

From screening to eConsent to onboarding and ongoing patient monitoring, our streamlined user journeys have helped clients around the world accelerate time to “first patient in” and engage and retain participants through the study and beyond with minimal dropout.

Powering digital-first clinical research

eConsent

eCOA/ePRO

Telemedecine

Connected devices

Outstanding recruitment and engagement in a digital clinical trial

The fully virtual DeTAP trial shows just how effective a decentralized design can be for enrollment. In the first days of the trial, 94% of participants were recruited and consented to the study, all fully remotely.

ENGAGE. INVOLVE. INFORM

SAMD for Pharma

SAMD for Pharma

Keep your trial participants engaged with multiple touch points

Keep your trial participants engaged with multiple touch points

Daily check-in support, application alerts and notifications, site-to-participant messaging and Televisits enable seamless communication and deliver higher participant engagement.

Daily check-in support, application alerts and notifications, site-to-participant messaging and Televisits enable seamless communication and deliver higher participant engagement.

EXPERIENCE. DESIGNED.

SAMD for Pharma

SAMD for Pharma

Award winning, intuitive design encourages data entry and usage

Award winning, intuitive design encourages data entry and usage

Based on more than a decade of experience working directly with patients, Huma’s platform is easy to use and quick to deploy. We boast 90-95% patient adherence and retention rates across our deployments, and are a proud recipient of the prestigious 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'.

Based on more than a decade of experience working directly with patients, Huma’s platform is easy to use and quick to deploy. We boast 90-95% patient adherence and retention rates across our deployments, and are a proud recipient of the prestigious 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'.

Our easy-to-use patient dashboard gives researchers direct access to key metrics and meaningful health indicators. While our ergonomic screen layout allows for quick and easy ePRO data entry.

Our easy-to-use patient dashboard gives researchers direct access to key metrics and meaningful health indicators. While our ergonomic screen layout allows for quick and easy ePRO data entry.

Designed with flexibility in mind, you can extend trial participation rates by easily adding caregivers to assist with data entry on behalf of the participant (eg: for pediatrics, and other trials where participants may find it difficult to enter data manually).

Designed with flexibility in mind, you can extend trial participation rates by easily adding caregivers to assist with data entry on behalf of the participant (eg: for pediatrics, and other trials where participants may find it difficult to enter data manually).

PATIENT EDUCATION

SAMD for Pharma

SAMD for Pharma

Build participant confidence with the ‘Learn’ module

Build participant confidence with the ‘Learn’ module

Huma’s ‘Learn’ module, easily accessible from the Huma app, helps your participants understand what to expect from your trial, with explainer videos, FAQs, disease education, dietary guidance and more as standard.

Huma’s ‘Learn’ module, easily accessible from the Huma app, helps your participants understand what to expect from your trial, with explainer videos, FAQs, disease education, dietary guidance and more as standard.

Regulatory, safety and compliance

Regulatory, safety and compliance

EU MDR 2017/745
Class IIb certified

MHRA registered Medical Device Class IIb

21CFR820 US FDA Class II

US Food and Drug Administration Medical Device 510k # K230214

ISO certifications

ISO 13485: 2016 certified (Medical Devices: Quality Management Systems)


ISO 27001: 2022 certified

Data protection / infosec

Committed to GDPR compliance


NHS Registration on Data Security and Protection Toolkit


CyberEssentials / CyberEssentials Plus

RELIABLE. SCALABLE. COST-EFFICIENT.

SAMD for Pharma

SAMD for Pharma

Save time and set-up costs with self-serve and fully-managed options

Our fully-regulated platform can be deployed across multiple countries and offers reliability and a high degree of user acceptance at scale.
Our powerful, modular platform includes pre-built components including eConsent, ePRO and eCOA that can be configured and adapted to your specific protocol and are ready to deploy on any cloud, saving time and reducing costs.

Article

How our Huma app drives engagement in population health research

Read more

Article

How our Huma app drives engagement in population health research

Read more

Article

How our Huma app drives engagement in population health research

Read more

Article

Largest decentralised study of its kind shows high levels of engagement with Huma’s study app

Read more

Article

Largest decentralised study of its kind shows high levels of engagement with Huma’s study app

Read more

Article

Largest decentralised study of its kind shows high levels of engagement with Huma’s study app

Read more

Request a meeting

Huma is committed to respecting your privacy, and we’ll only use your personal details to provide information you have selected you’re interested in. Review our Privacy Policy for further information.

We’d love to send you our monthly newsletter about our latest work, research and events by email. We’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes.

Sources

  1. Range of data from across a number of Huma projects